Skip to content
GLP-1 Savers

Head-to-head · Value Score

CoreAge Rx vs Vytora Health

Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 81, Vytora Health a 82. Here's what each one really costs past month one — and where each one bites back.

CoreAge Rx

Grade B · Good Value

Advertised price

From $79/mo

From $79/mo (compounded semaglutide; confirm total at checkout)

Get this deal Full CoreAge Rx review →
VS
★ Better value

Vytora Health

Grade B+ · Good Value

Advertised price

From $180/mo

From $180/mo (all doses, compounded)

Get this deal Full Vytora Health review →

The verdict

Better value: Vytora Health

Vytora Health takes it on Value Score, 82 to 81 — an est. From $180/mo (all doses, compounded) first month, though we flag its pricing to watch. CoreAge Rx isn't out of it: Someone comparing low advertised injection prices who is prepared to confirm the pharmacy, state eligibility and full payment terms before submitting an order.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealCoreAge RxVytora Health
Value Score81 (B)82 (B+)
Advertised priceFrom $79/mo (compounded semaglutide; confirm total at checkout)From $180/mo (all doses, compounded)
Save vs brand self-pay——
SemaglutideFrom $79/mo (compounded injection; confirm total at checkout)From $180/mo (all doses, compounded)
TirzepatideFrom $129/mo (compounded injection; confirm total at checkout)From $249/mo (all doses, compounded)
Both moleculesYesYes
PricingWatchWatch
CoverageU.S., state limits shown at intakeAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

Lowest Real Price
CoreAge Rx: 88. Vytora Health: 76.
No Teaser-Rate Bait
CoreAge Rx: 74. Vytora Health: 80.
Nationwide Availability
CoreAge Rx: 45. Vytora Health: 96.
Both Molecules
CoreAge Rx: 95. Vytora Health: 92.
Easy Cancellation
CoreAge Rx: 88. Vytora Health: 68.
Reputation
CoreAge Rx: 84. Vytora Health: 95.

CoreAge Rx

CoreAge Rx advertises compounded semaglutide from $79 and tirzepatide from $129 per month, with dose-flat pricing stated in its FAQ. Confirm the total and refund terms before paying.

What's good

  • CoreAge Rx publishes separate product prices for both molecules: semaglutide from $79 per month and tirzepatide from $129. That gives you two actual medication offers to compare rather than one generic GLP-1 starting figure.
  • CoreAge Rx's FAQ says the price locked in at checkout stays the same in future months regardless of dose increases. I would save that confirmation with the order, because a low starting price matters much more when the prescribed maintenance dose costs the same.
  • The product pages state that there are no long-term contracts or membership fees and advertise fast, free delivery. Compare those inclusions with the checkout total; the refund policy separately allows applicable consultation fees and shipping charges if disclosed there.
  • CoreAge Rx uses the MD Integrations professional entities for medical care and prescribing. Its FAQ names physicians assigned in California, Massachusetts, Rhode Island and Vermont, giving patients in those states a concrete medical contact to verify.
  • CoreAge Rx offers account-based reordering and cancellation, and its help center says optional subscriptions can be managed in the member portal. Check whether your selected purchase is a one-time order or an automatically renewed subscription so the next charge is predictable.
  • CoreAge Rx also advertises microdosing products at $79 for semaglutide and $129 for tirzepatide. These are separate lower-dose offers, not a reason to select your own dose or evidence that they work like the doses studied for approved products.

The fine print

  • CoreAge Rx's FAQ promises an automatic 100% refund if the clinician declines your prescription, but its refund policy says applicable consultation fees of $50–$100 are nonrefundable. Ask which policy applies to the exact order and how much would be returned before you pay.
  • CoreAge Rx's refund policy makes a medication order final once the prescription is approved and sent to the pharmacy, which can happen before shipping. Waiting until the parcel is dispatched may be too late to cancel an order or recover the medication charge. The policy also imposes a 30-day nonrefundable cutoff even when incomplete documentation has prevented fulfillment.
  • CoreAge Rx does not publish a complete GLP-1 state list. Its FAQ says therapy-specific state restrictions are confirmed during intake, so a U.S. address alone does not establish that your selected medication is available where you live.
  • CoreAge Rx does not name the dispensing pharmacy in its FAQ; it asks patients to contact support. Obtain the pharmacy's legal name, license and contact information before choosing a compounded prescription. The platform's branding does not identify who prepares your medication.
  • CoreAge Rx's FAQ says there are no automatic rebills, while its refund policy and help center describe optional automatic renewals. I would confirm the selected purchase option and next charge date rather than treat the general FAQ answer as a guarantee for every order.
  • CoreAge Rx offers compounded medication, which is not FDA-approved. Its FAQ says tirzepatide is typically formulated with B12 and that requests without it go to the prescriber. Ask why the exact formulation is appropriate for you; an added vitamin does not itself establish a lawful patient-specific difference.

Vytora Health

Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides.

What's good

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)

The fine print

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail
Get the CoreAge Rx deal Get the Vytora Health deal

We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Vytora Health.

More head-to-heads

The programs scoring closest to this pair, side by side.

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.